These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 23979023)
1. Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer's disease. Sun YX; Ji X; Mao X; Xie L; Jia J; Galvan V; Greenberg DA; Jin K J Alzheimers Dis; 2014; 38(2):437-44. PubMed ID: 23979023 [TBL] [Abstract][Full Text] [Related]
2. Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature. Caccamo A; De Pinto V; Messina A; Branca C; Oddo S J Neurosci; 2014 Jun; 34(23):7988-98. PubMed ID: 24899720 [TBL] [Abstract][Full Text] [Related]
3. Taking aim at Alzheimer's disease through the mammalian target of rapamycin. Maiese K Ann Med; 2014 Dec; 46(8):587-96. PubMed ID: 25105207 [TBL] [Abstract][Full Text] [Related]
4. mTOR Hyperactivation in down syndrome hippocampus appears early during development. Iyer AM; van Scheppingen J; Milenkovic I; Anink JJ; Adle-Biassette H; Kovacs GG; Aronica E J Neuropathol Exp Neurol; 2014 Jul; 73(7):671-83. PubMed ID: 24918639 [TBL] [Abstract][Full Text] [Related]
5. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling. Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906 [TBL] [Abstract][Full Text] [Related]
6. Rapamycin inhibits activation of AMPK-mTOR signaling pathway-induced Alzheimer's disease lesion in hippocampus of rats with type 2 diabetes mellitus. Sun Q; Wei LL; Zhang M; Li TX; Yang C; Deng SP; Zeng QC Int J Neurosci; 2019 Feb; 129(2):179-188. PubMed ID: 29962282 [TBL] [Abstract][Full Text] [Related]
7. Beneficial Effects of Early mTORC1 Inhibition after Traumatic Brain Injury. Nikolaeva I; Crowell B; Valenziano J; Meaney D; D'Arcangelo G J Neurotrauma; 2016 Jan; 33(2):183-93. PubMed ID: 26122481 [TBL] [Abstract][Full Text] [Related]
8. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells. Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880 [TBL] [Abstract][Full Text] [Related]
9. mTOR-mediated hyperphosphorylation of tau in the hippocampus is involved in cognitive deficits in streptozotocin-induced diabetic mice. Wang S; Zhou SL; Min FY; Ma JJ; Shi XJ; Bereczki E; Wu J Metab Brain Dis; 2014 Sep; 29(3):729-36. PubMed ID: 24682776 [TBL] [Abstract][Full Text] [Related]
10. Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage. Völkers M; Konstandin MH; Doroudgar S; Toko H; Quijada P; Din S; Joyo A; Ornelas L; Samse K; Thuerauf DJ; Gude N; Glembotski CC; Sussman MA Circulation; 2013 Nov; 128(19):2132-44. PubMed ID: 24008870 [TBL] [Abstract][Full Text] [Related]
12. Mammalian target of rapamycin complex 1 (mTORC1) and 2 (mTORC2) control the dendritic arbor morphology of hippocampal neurons. Urbanska M; Gozdz A; Swiech LJ; Jaworski J J Biol Chem; 2012 Aug; 287(36):30240-56. PubMed ID: 22810227 [TBL] [Abstract][Full Text] [Related]
13. Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell Activation. Walker NM; Belloli EA; Stuckey L; Chan KM; Lin J; Lynch W; Chang A; Mazzoni SM; Fingar DC; Lama VN J Biol Chem; 2016 Mar; 291(12):6262-71. PubMed ID: 26755732 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Van Skike CE; Jahrling JB; Olson AB; Sayre NL; Hussong SA; Ungvari Z; Lechleiter JD; Galvan V Am J Physiol Heart Circ Physiol; 2018 Apr; 314(4):H693-H703. PubMed ID: 29351469 [TBL] [Abstract][Full Text] [Related]
15. Chronic Binge Alcohol Exposure During Pregnancy Alters mTOR System in Rat Fetal Hippocampus. Lee J; Lunde-Young R; Naik V; Ramirez J; Orzabal M; Ramadoss J Alcohol Clin Exp Res; 2020 Jun; 44(6):1329-1336. PubMed ID: 32333810 [TBL] [Abstract][Full Text] [Related]
16. Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis. Wen ZH; Su YC; Lai PL; Zhang Y; Xu YF; Zhao A; Yao GY; Jia CH; Lin J; Xu S; Wang L; Wang XK; Liu AL; Jiang Y; Dai YF; Bai XC Oncogene; 2013 Jan; 32(2):160-70. PubMed ID: 22349822 [TBL] [Abstract][Full Text] [Related]
17. Identification of rictor as a novel substrate of Polo-like kinase 1. Shao T; Liu X Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006 [TBL] [Abstract][Full Text] [Related]
20. Loss of mTOR signaling affects cone function, cone structure and expression of cone specific proteins without affecting cone survival. Ma S; Venkatesh A; Langellotto F; Le YZ; Hall MN; Rüegg MA; Punzo C Exp Eye Res; 2015 Jun; 135():1-13. PubMed ID: 25887293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]